No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr7:25900000-25902800 |
Active TSS |
NHDF-Ad |
bronchial
|
2 |
chr7:25900000-25903800 |
Active TSS |
K562 |
blood
|
3 |
chr7:25900400-25902600 |
Active TSS |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
4 |
chr7:25900800-25902800 |
Active TSS |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
5 |
chr7:25901000-25902400 |
Bivalent/Poised TSS |
Rectal Mucosa Donor 29 |
rectum
|
6 |
chr7:25901200-25902600 |
Active TSS |
Bone Marrow Derived Cultured Mesenchymal Stem Cells |
Bone marrow
|
7 |
chr7:25901200-25902600 |
Bivalent Enhancer |
Fetal Heart |
heart
|
8 |
chr7:25901400-25902200 |
Bivalent Enhancer |
Primary T helper 17 cells PMA-I stimulated |
--
|
9 |
chr7:25901400-25902200 |
Active TSS |
Colonic Mucosa |
Colon
|
10 |
chr7:25901400-25902400 |
Bivalent/Poised TSS |
Skeletal Muscle Male |
skeletal muscle
|
11 |
chr7:25901400-25902600 |
Bivalent/Poised TSS |
Ganglion Eminence derived primary cultured neurospheres |
brain
|
12 |
chr7:25901400-25902600 |
Active TSS |
Skeletal Muscle Female |
skeletal muscle
|
13 |
chr7:25901400-25902600 |
Bivalent/Poised TSS |
GM12878-XiMat |
blood
|
14 |
chr7:25901400-25902800 |
Bivalent Enhancer |
Primary hematopoietic stem cells |
blood
|
15 |
chr7:25901400-25903000 |
Bivalent Enhancer |
Primary T killer memory cells from peripheral blood |
blood
|
16 |
chr7:25901400-25903000 |
Bivalent Enhancer |
Fetal Adrenal Gland |
Adrenal Gland
|
17 |
chr7:25901600-25902200 |
Bivalent Enhancer |
Primary monocytes fromperipheralblood |
blood
|
18 |
chr7:25901600-25902200 |
Bivalent Enhancer |
Primary T helper cells fromperipheralblood |
blood
|
19 |
chr7:25901600-25902200 |
Bivalent Enhancer |
Fetal Intestine Large |
intestine
|
20 |
chr7:25901600-25902200 |
Flanking Bivalent TSS/Enh |
Fetal Thymus |
thymus
|
21 |
chr7:25901600-25902600 |
Active TSS |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
22 |
chr7:25901600-25902600 |
Active TSS |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
23 |
chr7:25901600-25902600 |
Bivalent/Poised TSS |
Brain Germinal Matrix |
brain
|
24 |
chr7:25901600-25902600 |
Bivalent/Poised TSS |
Fetal Brain Female |
brain
|
25 |
chr7:25901600-25902600 |
Bivalent/Poised TSS |
Rectal Smooth Muscle |
rectum
|
26 |
chr7:25901600-25902600 |
Active TSS |
A549 |
lung
|
27 |
chr7:25901600-25902800 |
Active TSS |
Psoas Muscle |
Psoas
|
28 |
chr7:25901600-25903000 |
Active TSS |
hESC Derived CD184+ Endoderm Cultured Cells |
ES cell derived
|
29 |
chr7:25901600-25903000 |
Flanking Bivalent TSS/Enh |
Monocytes-CD14+_RO01746 |
blood
|
30 |
chr7:25901800-25902200 |
Bivalent Enhancer |
Primary T cells fromperipheralblood |
blood
|
31 |
chr7:25901800-25902200 |
Bivalent Enhancer |
Aorta |
Aorta
|
32 |
chr7:25901800-25902400 |
Bivalent/Poised TSS |
Primary T cells from cord blood |
blood
|
33 |
chr7:25901800-25902400 |
Enhancers |
Muscle Satellite Cultured Cells |
--
|
34 |
chr7:25901800-25902400 |
Bivalent/Poised TSS |
Hela-S3 |
cervix
|
35 |
chr7:25901800-25902400 |
Weak transcription |
HMEC |
breast
|
36 |
chr7:25901800-25902600 |
Weak transcription |
ES-I3 Cell Line |
embryonic stem cell
|
37 |
chr7:25901800-25902600 |
Active TSS |
Primary hematopoietic stem cells short term culture |
blood
|
38 |
chr7:25901800-25902600 |
Flanking Bivalent TSS/Enh |
Primary T helper cells PMA-I stimulated |
--
|
39 |
chr7:25901800-25902600 |
Active TSS |
Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells |
embryonic stem cell
|
40 |
chr7:25901800-25902600 |
Bivalent Enhancer |
Placenta |
Placenta
|
41 |
chr7:25901800-25902800 |
Enhancers |
HUES48 Cell Line |
embryonic stem cell
|
42 |
chr7:25901800-25902800 |
Bivalent Enhancer |
Primary T cells effector/memory enriched fromperipheralblood |
blood
|
43 |
chr7:25901800-25902800 |
Bivalent Enhancer |
Primary Natural Killer cells fromperipheralblood |
blood
|
44 |
chr7:25901800-25902800 |
Flanking Bivalent TSS/Enh |
Thymus |
Thymus
|
45 |
chr7:25901800-25903000 |
Bivalent Enhancer |
Primary B cells from peripheral blood |
blood
|
46 |
chr7:25901800-25903000 |
Bivalent Enhancer |
Fetal Stomach |
stomach
|
47 |
chr7:25901800-25903000 |
Bivalent Enhancer |
Stomach Mucosa |
stomach
|
48 |
chr7:25902000-25902200 |
Weak transcription |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
49 |
chr7:25902000-25902200 |
Flanking Bivalent TSS/Enh |
Primary T helper naive cells fromperipheralblood |
blood
|
50 |
chr7:25902000-25902200 |
Bivalent Enhancer |
Liver |
Liver
|